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Abstract
Mutations in mitochondrial DNA are an important source of severe and incurable human dis-
eases. The vast majority of these mutations are heteroplasmic, meaning that mutant and
wild-type genomes are present simultaneously in the same cell. Only a very high proportion
of mutant mitochondrial DNA (heteroplasmy level) leads to pathological consequences. We
previously demonstrated that mitochondrial targeting of small RNAs designed to anneal with
mutant mtDNA can decrease the heteroplasmy level by specific inhibition of mutant mtDNA
replication, thus representing a potential therapy. We have also shown that 5S ribosomal
RNA, partially imported into human mitochondria, can be used as a vector to deliver anti-
replicative oligoribonucleotides into human mitochondria. So far, the efficiency of cellular
expression of recombinant 5S rRNA molecules bearing therapeutic insertions remained
very low. In the present study, we designed new versions of anti-replicative recombinant 5S
rRNA targeting a large deletion in mitochondrial DNA which causes the KSS syndrome, ana-
lyzed their specific annealing to KSS mitochondrial DNA and demonstrated their import into
mitochondria of cultured human cells. To obtain an increased level of the recombinant 5S
rRNA stable expression, we created transmitochondrial cybrid cell line bearing a site for Flp-
recombinase and used this system for the recombinase-mediated integration of genes cod-
ing for the anti-replicative recombinant 5S rRNAs into nuclear genome. We demonstrated
that stable expression of anti-replicative 5S rRNA versions in human transmitochondrial
cybrid cells can induce a shift in heteroplasmy level of KSS mutation in mtDNA. This shift
was directly dependent on the level of the recombinant 5S rRNA expression and the
sequence of the anti-replicative insertion. Quantification of mtDNA copy number in trans-
fected cells revealed the absence of a non-specific effect on wild type mtDNA replication,
indicating that the decreased proportion between mutant and wild type mtDNA molecules is
not a consequence of a random repopulation of depleted pool of mtDNA genomes. The het-
eroplasmy change could be also modulated by cell growth conditions, namely increased by
cells culturing in a carbohydrate-free medium, thus forcing them to use oxidative phosphory-
lation and providing a selective advantage for cells with improved respiration capacities. We
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discuss the advantages and limitations of this approach and propose further development of
the anti-replicative strategy based on the RNA import into human mitochondria.
Introduction
Mitochondria are essential organelles of human cells because of their fundamental roles in sev-
eral critical cellular processes including energy generation, Fe-S clusters production, calcium
homeostasis and apoptosis. They contain their own genome, in multiple copies per cell, allow-
ing the synthesis of 13 polypeptides which are all essential components of the mitochondrial
oxidative phosphorylation complexes in human cells. Mutations in mitochondrial DNA
(mtDNA) have been associated with a wide variety of human disorders ranging from optic
atrophy, deafness, diabetes to peripheral neuropathy or myopathy [1]. Most of the pathogenic
mutations in human mtDNA are heteroplasmic (i.e. coexistence of mutant and wild-type
genomes in a same cell) and their phenotypic expression is intimately linked to the ratio
between mutant mtDNA molecules and wild-type ones (heteroplasmy level) [2]. This ratio can
be variable in different tissues of the patient and even in different cells of the same tissue and
can change with age [3]. Phenotypic expression of mtDNA mutations can be different for the
various loads of the same mutation [4]. Typically, the biochemical defects and associated
symptoms will only appear if the heteroplasmy level exceeds a given threshold generally com-
prised between 60% and 95% of mutant mtDNA, and subtle heteroplasmy changes can have
dramatic effects on a patient’s phenotype. Thus, the downshift of heteroplasmy level could
potentially provide a therapeutic strategy for the mitochondrial disorders, and several labora-
tories work for establishing methods for removing detrimental mtDNA sequences (rev. in [5]).
For instance, the anti-genomic strategy consists in the specific cleavage of mutant mtDNA
by targeted specific endonucleases [6], zinc finger nuclease [7] or transcription activator-like
effector nuclease (TALEN) [8, 9]. Limitations of this strategy consist in important off-target
cleavage, which leads to elimination of more than 85% of mtDNA pool thus decreasing the
therapeutic potential (as it was recently demonstrated by Gammage et al. [10]), and the chal-
lenge to engineer the protein which has to recognize specific DNA sequences. MitoTALENs
specificity also depends on the sequence of the DNA target site and thus not all the point muta-
tions can be discriminated from the wild-type sequences [10].
Another approach, so-called anti-replicative strategy, consists in targeting mitochondria
with small molecules able to specifically anneal with mutant mtDNA and to interfere with its
replication [11, 12]. Many organisms import non-coding cytosolic RNAs into the mitochon-
dria (rev. in [13–15]). Our team has studied the molecular mechanisms of yeast tRNALys
import into yeast and human mitochondria [16, 17] and identified structural import determi-
nants able to target oligonucleotides into mitochondria of human cells [18]. These mitochon-
drial RNA vectors had been applied to target anti-replicative oligonucleotides, designed to
specifically anneal with mutant mtDNA, into human mitochondria. In these studies, RNA
mitochondrial import induced the heteroplasmy shift in several cellular models: a) human
cybrid cells and patient’s fibroblasts bearing a heteroplasmic point mutation in ND5 gene [19]
and b) human cybrid cell line bearing 60% of mtDNA affected by a large deletion (nucleotides
8363–15438) underlying a case of frequent mitochondrial pathology, the Kearns Sayre Syn-
drome (KSS) [12].
Another type of RNA mitochondrial vectors is based on 5S rRNA expressed in nucleus and
partially imported into human mitochondria [20–22]. 5S rRNA is a highly conserved and
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essential component of the large ribosomal subunit of all organisms, the only exceptions being
mitochondrial ribosomes of yeast and mammals [23]. However, 5S rRNA seems to be the
most abundantly imported RNA in mammalian mitochondria. Our studies demonstrated that
5S rRNA import mechanism relies on protein factors identified as the mitochondrial enzyme
rhodanese and the precursor of mitochondrial ribosomal protein MRP-L18 [24, 25], interact-
ing with two structural motifs located in the α and γ domains of 5S rRNA (Fig 1a), while a
third motif corresponding to the distal part of the β domain and allowing the interaction with
cytosolic ribosomal protein L5 may be either deleted or replaced without loss of import capac-
ity [26]. This finding was exploited to demonstrate that 5S rRNA can function as a vector to
deliver oligoribonucleotides into human mitochondria.
Our previous attempts to stably express 5S rRNA-based recombinant RNA (rec.5S rRNAs)
in human cybrid cells resulted in a very weak expression level, estimated at merely 30±5 mole-
cules per cell, though it allowed a moderate heteroplasmy shift. Moreover, variation in the
Fig 1. Secondary structure of wild type and recombinant 5S rRNAs. (a) Human 5S rRNA secondary structure, modified from [26]. (b) 2D structure of rec.5S
rRNA versions, mfold predictions corrected manually. Sequences of the anti-replicative insertions (shown in red) correspond to boundaries of the KSS deletion in
mtDNA; arrows indicate the deletion point.
https://doi.org/10.1371/journal.pone.0199258.g001
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rec.5S rRNAs expression obtained in different clones of transfected cells led to diverse effects
on the mitochondrial heteroplasmy level (no shifts were detected in 70% of clones) [12].
In the present study, we aimed to increase the expression level of anti-replicative rec.5S
rRNAs in human cybrid cells in a stable manner, and to verify if this expression can decrease
the proportion of mutant mtDNA.
Results
Design of recombinant 5S rRNA molecules
To use 5S rRNA as a mitochondrial vector targeting mtDNA molecules affected by the KSS
deletion, the distal portion of the β-domain of 5S rRNA (Fig 1a) was replaced by sequences
corresponding to either H- or L-strand (standard annotation of two mtDNA strands, Heavy
and Light ones) of the mtDNA at the junction of the KSS deletion boundaries [12].
Previously, we designed two rec.5S rRNA versions bearing insertions corresponding to 13
nucleotides of the H-strand (5S-KSS-13H) or to 14 nucleotides of the L-strand (5S-KSS-14L)
[12]. RNA 5S-KSS-13H was shown to be efficiently imported into isolated human mitochon-
dria in vitro as well as in vivo, in cells transfected with corresponding RNA transcript [26]. In
addition to these rec.5S rRNAs, we designed two new versions bearing insertions of 15 nucleo-
tides (5S-KSS-15H and 5S-KSS-15L). For all these rec.5S rRNAs, the secondary structure pre-
dictions have been thoroughly analyzed (Fig 1b). All the versions were characterized by a
classical 5S rRNA scaffold where the structure of the regions needed for interaction with tran-
scription factor TFIIIA and the structural determinants of mitochondrial import have not
been altered. Cofold analysis of the annealing between rec.5S rRNAs and the mutant mtDNA
allowed prediction the length of the duplex region corresponding to 14 and 15 bp for 5S-KSS-
14L and 5S-KSS-15L versions, and being slightly longer for 5S-KSS-13H and 5S-KSS-15H mol-
ecules (15 and 17 bp respectively, Fig 2). According to melting temperature predictions, Tm
values are also different for rec.5S rRNAs targeting the L-strand of mtDNA (52.1˚C and
56.6˚C) and those targeting the H-strand (45.2˚C and 48.9˚C). Annealing of rec.5S rRNAs to
wild-type mtDNA should be negligible at 37˚C. This has been directly demonstrated by in
vitro hybridizations of labeled rec.5S rRNAs with mtDNA fragments under physiological con-
ditions (S1 Fig); the signal can be detected only for mutant mtDNA but not for the fragments
of wild type mtDNA.
Import of rec.5S rRNA molecules into human mitochondria
To evaluate the import efficiency of rec.5S rRNA variants in vivo, we transfected human cells
with corresponding T7 transcripts as described previously [27]; RNA isolated from cells and
from purified mitoplasts were analyzed by Northern blot hybridization (Fig 3 and S2 Fig).
Hybridization with a probe to mt tRNAVal clearly demonstrates the enrichment of mito-
chondrial RNA transcript in mitoplasts preparations (this is not so visible for 5S-KSS-13H
transfection, since a larger amount of total RNA was loaded on gel). Comparing to this enrich-
ment, the levels of cytosolic contamination (probe to 5.8S rRNA) in mitoplasts fractions were
quite negligible (<5%), therefore the samples can be used for quantification. To estimate the
import efficiencies for various rec.5S rRNA, the ratio between the signals of the rec.5S rRNA
in the mitoplast fraction and in total RNA preparation was normalized to that of the mito-
chondrial tRNAVal in the same samples as described previously [26] (for details, see the Mate-
rials and methods section). Resulting import efficiencies obtained upon quantification of two
transfection experiments were expressed as a percentage of the endogenous wild type 5S rRNA
import efficiency (taken as 100%) estimated in control non-transfected cells (Table 1 and S2
Table).
MtDNA heteroplasmy modulation
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The data demonstrate that all the rec.5S rRNA molecules can be imported into human
mitochondria at the levels comparable with that of endogenous 5S rRNA. Surprisingly, only
one version, 5S-KSS-13H, was characterized by improved import abilities. The reasons for this
are uncertain, additional studies of folding and detailed structure of this RNA molecule can
help to further improvement of the recombinant RNA import into mitochondria.
Stable expression of rec.5S rRNA in human cybrid cells
Attempting to obtain an increased level of the stable expression of selected rec.5S rRNAs in
human cybrid cells, we used the Flp recombinase-mediated integration of a gene of interest
into specific genomic location by Flp-In™ T-Rex™ Core system (Invitrogen). To check the
impact of rec.5S rRNA stable expression on the heteroplasmy level, we first had to introduce
the FRT site into nuclear genome of the KSS cybrid cell line. These cells, obtained by the fusion
of the patient’s cytoplasts with nuclei of immortalized osteosarcoma cells, contain a heteroplas-
mic population of mutant and wild type mtDNA molecules and were characterized by a small
decrease of oxygen consumption [12]. Zeocin-resistant clones obtained after transfection with
the pFRT/lacZeo plasmid were characterized by similar growth rates and by a single integrated
FRT site, as determined by Southern blot hybridization (S3 Fig).
Because integration of the pFRT/lacZeo plasmid into the genome occurs randomly, expres-
sion levels of the lacZ-Zeocin fusion gene will be dependent on the transcriptional activity of
the surrounding sequences at the integration site. Thus, Zeocin-resistant clones were screened
for β-galactosidase activity levels. For all of them, specific β-gal activities were 4 to 8-fold lower
compared to the commercial HEK 293 T-Rex™ Flp-In ™ cells (S3 Table). Clone 5, selected for
further experiments (referred to as FRT-KSS cell line), was characterized by the highest β-gal
activity and by 51±5% KSS heteroplasmy level.
Fig 2. Structure and melting temperatures predictions for duplexes between rec.5S rRNA and mutant or wild-type mtDNA regions. Upper part of each
duplex corresponds to the anti-replicative insertion of rec.5S rRNA indicated at the left. Nucleotides complementary to the 5’ boundary of the KSS deletion are
shown in orange; those complementary to the 3’ deletion boundary are in green. 5S-KSS-13H and 5S-KSS-15H annealed to the L-strand of mtDNA; 5S-KSS-14L
and 5S-KSS-15L annealed to the H-strand of mtDNA.
https://doi.org/10.1371/journal.pone.0199258.g002
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Fig 3. In vivo test of rec.5S rRNA import into human mitochondria. Northern blot analysis of rec.5S rRNA variants in total (T) and mitoplast (M) RNA
preparations from cells transfected with various RNA, as indicated above the panels; NT, non-transfected cells; tr, 5ng of corresponding T7 transcript used for cell
transfection. Gels stained with Ethidium bromide (EthBr) and hybridized with probes indicated at the left are shown. Rec 5S, probes corresponding to the
insertion sequence specific for each rec.5S rRNA variant; 5.8S and Vmt, probes to cytosolic 5.8S rRNA and mitochondrial tRNAVal. 5S, probe to 5S rRNA, can
hybridize with endogenous 5S rRNA and with rec.5S rRNA versions (which are 5–8 nucleotides shorter), thus giving double bands clearly visible in 13H-M
sample. The long strip marked by  on the panel “tr13H, EthBr” is due to an artifact; 5ng of the transcript (tr13H) can be visible only by probing.
https://doi.org/10.1371/journal.pone.0199258.g003
MtDNA heteroplasmy modulation
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Genes of rec.5S rRNA versions with natural flanking regions were cloned into pcDNA™5/
FRT/TO vector and then integrated into FRT site of the nuclear genome of FRT-KSS cybrid
cell line. Expression levels of rec.5S rRNAs have been assayed by semi-quantitative RT-PCR
using corresponding T7-transcripts to create a calibration curve (Fig 4) and by real-time RT-
qPCR (S4 Table).
We performed several independent transfections of FRT-KSS cells with pcDNA™5/FRT/TO
plasmids. The first observation was that the expression of the transgenic rec.5S versions varied
in different cell lines even though the FRT system is dedicated to provide a controlled level of
expression directed from a given locus. Indeed, we generated lines either with high rec.5S
rRNAs expression levels (referred for as 5S-KSS-13H(1) and 5S-KSS-14L(1)), or those charac-
terized by low expression for 5S-KSS-13H, 5S-KSS-14L and 5S-KSS-15L, or a medium expres-
sion level for 5S-KSS-15H (Table 2 and S4 Table). One may explain the observed variability in
the expression level by multiple insertions of pcDNA™5/FRT/TO-13H and -14L plasmids into
nuclear genome in the case of the best expressers 5S-KSS-13H(1) and 5S-KSS-14L(1), while sin-
gle copy of rec.5S rRNA gene has been integrated in other transgenic lines. If this stands true,
it can indicate that the rec.5S rRNAs expression level could be improved by integration of mul-
tiple copies of rec.5S rRNA gene in nuclear genome.
Shift of the heteroplasmy levels in transgenic cell lines
To check if the stable expression of rec.5S rRNA molecules can induce a mtDNA heteroplasmy
shift in the human cybrid cells, we cultivated FRT-KSS cell lines for 8 weeks and measured the
mutant mtDNA load by real-time qPCR as described previously [12]. Cells issued from inde-
pendent transfections were cultivated separately, each one divided into 4 parallel cultures.
Table 1. Relative efficiencies of rec.5S rRNA mitochondrial import.
5S rRNA Relative import efficiency, % of endogenous 5S rRNA
Endogenous 5S rRNA 100%
5S-KSS-13H 200 ± 30
5S-KSS-14L 90 ± 5
5S-KSS-15L 70
5S-KSS-15H 90 ± 15
 Data of one transfection experiment
https://doi.org/10.1371/journal.pone.0199258.t001
Fig 4. Quantification of 5S-KSS-14L RNA expression by semi-quantitative RT-PCR. On the left, PAGE analysis of the RT-PCR reactions
performed on the total cellular RNA or known amounts of purified T7-transcripts, as indicated above the panel. On the right, an example of
the calibration curve used for quantification of 5S-KSS-14L RNA (in red) in cybrid cell line.
https://doi.org/10.1371/journal.pone.0199258.g004
MtDNA heteroplasmy modulation
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Total DNA was isolated from a portion of cells every 2 weeks and analyzed by 2–3 independent
qPCR experiments with each measure performed in triplicates. First, we compared the KSS
heteroplasmy levels in the transgene and control cell lines after cultivation in a high glucose
medium, but failed to detect any significant shift of the proportion between mutant and wild-
type mtDNA molecules during 8 weeks cultivation (Fig 5a, “high glucose” samples).
To investigate if the selection for better mitochondrial respiration could create an advantage
for cells with decreased heteroplasmy levels, we cultivated transgenic cells in a carbohydrate-
free medium. In these conditions, only pyruvate and amino acids are available as carbon
sources and cells should rely on mitochondrial oxidative phosphorylation to produce ATP.
Cybrid cells FRT-KSS were able to grow in a medium without addition of glucose and dem-
onstrated only little heteroplasmy variations after 8 weeks of culture (Fig 5a) indicating that
there were no significant random fluctuations in heteroplasmy. In all transfected cell lines with
low expression of rec.5S rRNA versions, a very moderate decrease of the KSS heteroplasmy
level has been observed in selective conditions. Statistically significant impact on the hetero-
plasmy has been detected only in 5S-KSS-15H expressing cells, where the mutation load was
shifted from 51±4% to 41±2% (P-value<0.01) (Fig 5a). For this cell line, we obtained a tiny
decrease (about 5% of heteroplasmy shift) after 4 weeks of cultivation (not shown), after 8
weeks we detected statistically significant decrease (10% of heteroplasmy shift), and this level
didn’t change during further cultivation up to 4 months, and remained stable after freezing-
thawing of the cells.
We next applied selective conditions to the cell lines with best expression of a rec.5S rRNA,
namely 5S-KSS-13H(1) and 5S-KSS-14L(1). In the case of 5S-KSS-13H(1), proportion of the
mutant mitochondrial genomes has been significantly decreased in a clear time-dependent
manner to reach 13±3% (Fig 5b). This level was thereafter stable during cell cultivation in a
media either with or without glucose. Noteworthy, the 5S-KSS-13H RNA was characterized by
2 fold improved import into mitochondria (Table 1), which may explain, along with its high
expression, the improved effect on the heteroplasmy load compared to the other rec.5S rRNA
versions.
We suppose that the stable expression and mitochondrial import of the anti-replicative 5S
rRNAs in cybrid cells can induce a shift of equilibrium between mutant and wild-type mito-
chondrial genomes. This shift can be more or less dramatic depending on the level of 5S rRNA
expression. Thereafter, cells can adapt to a new equilibrium (may be by reprogramming of
metabolic pathways, as it was demonstrated for MELAS mutation in [4]) and the obtained new
heteroplasmy level remains stable during further cultivation.
On the other hand, high expression of the 5S-KSS-14L(1) version did not induce an impor-
tant decrease of heteroplasmy. Since two rec.5S rRNA versions, 13H and 14L, are designed to
target different mtDNA strands, one can hypothesize that the different anti-replication action
of these rec.5S rRNA molecules may be related to the asymmetric replication mechanism spe-
cific for mammalian mtDNA (see Discussion for details).
Table 2. Amounts of anti-replicative molecules in rec.5S rRNA expressing cell lines.
Rec.5S rRNA Number of rec.5S rRNA/cell
5S-KSS-13H(1) 2000±200
5S-KSS-13H 200±30
5S-KSS-14L(1) 2000±200
5S-KSS-14L 300±50
5S-KSS-15H 1300±200
5S-KSS-15L 200±30
https://doi.org/10.1371/journal.pone.0199258.t002
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Fig 5. Effect of rec.5S rRNA expression on the heteroplasmy level of KSS mutation. (a) Proportion of KSS mtDNA
(Y axis) in cybrids cell lines with low expression of rec.5S rRNA versions (see Table 1) after 8 weeks of cultivation in
high glucose or glucose-free media, as indicated. (b) Time-depended decrease of KSS mutation load in cells expressing
high amounts of rec.5S rRNAs 5S-KSS-13H(1) and 5S-KSS-14L(1) in glucose-free medium. (c) MtDNA copy numbers
normalized to nuclear gene TST1, measured in the same cell populations as in (b). Cells issued from independent
transfections were cultivated separately; each population was divided into 4 parallel cultures. Total DNA was isolated
from a portion of each cell cultures every 2 weeks and analysed by 2–3 independent qPCR experiments, each measure
performed in triplicates. Standard deviations are calculated from qPCR data obtained on the independently cultured
cells (n = 4). Statistical differences were determined with a two-tailed Student’s t-test (, p< 0.05; , p< 0.01; ,
p< 0.001).
https://doi.org/10.1371/journal.pone.0199258.g005
MtDNA heteroplasmy modulation
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To ascertain the absence of a non-specific effect on replication that could reduce total
mtDNA copy number in transfected cells, we estimated mtDNA amounts in FRT-KSS cybrid
cell line before transfection, and in 5S-KSS-13H(1) and 5S-KSS-14L(1) cells after 4 and 8 weeks
of cultivation in glucose-free medium (Fig 5c). Using real-time PCR, we measured a copy
number of all mtDNA molecules (gene 12S rRNA) compared to nuclear DNA (gene of rhoda-
nese TST1). We detected20% decrease of mtDNA copy number in 5S-KSS-13H(1) cell line.
In theory, inhibition of the replication of 50% of mtDNA genomes (bearing KSS mutation)
should cause a 25% decrease of mtDNAcn after one round of the replication. It is difficult to
build a mathematical model for the action of anti-replicative molecules, since we do not know
the velocity of mtDNA replication and exact level of affected mutant genomes. Still, some
small level of mtDNA copy number downshift can be anticipated. Noteworthy, in case of an
unspecific effect on mitochondrial replication process, we might expect a much more impor-
tant depletion of mtDNA due to replication stalling of both, mutant and wild type mitochon-
drial genomes. Therefore, our results indicate that no depletion effect has been caused by an
eventual off-target effect on the wild-type mtDNA replication.
Obtained new data indicate that the impact of anti-replicative rec.5S rRNA molecules on
the mutant mtDNA load is strongly dependent on the amount of rec.5S rRNA molecules.
High levels of RNA expression and mitochondrial import seem to be necessary to affect the
mutant mtDNA replication and thus change the proportion between mutant and wild-type
mitochondrial genomes.
Discussion
5S rRNA as a mitochondrial RNA vector
Natural pathway of small non-coding RNA trafficking into mitochondria has been described
in phylogenetic groups as diverse as protozoan, plants, fungi and animals [28, 29]. Small 5S
ribosomal RNA is one of the most abundant cytosolic RNA imported into mitochondria. It
had been reported that 5S rRNAs are expressed from large nuclear gene arrays (100–200
genes) and that a small portion of its cellular pool can readily be found within mitochondria in
different organisms, from flies to humans [20, 21, 30]. In mammals, the mitochondrial func-
tion of 5S rRNA is not known. Cryo-electronic microscopy analysis recently demonstrated
that the mitochondrial ribosomes from pig liver and human cultured cells do not contain 5S
rRNA, but its place in the central protuberance of the large ribosomal subunit is occupied by
mitochondrial tRNAPhe or tRNAVal correspondingly [31, 32]. The absence of the canonical
function for 5S rRNA in human mitochondria raised some doubts concerning its mitochon-
drial import [33, 34]. This opinion, not supported by direct experimental data, does not make
a distinction between two independent points: 1) mitochondrial localization of a small portion
of the cytosolic 5S rRNA pool and 2) 5S rRNA integration into the large subunit of the mito-
chondrial ribosome. The absence of 5S rRNA in the large ribosomal subunit does not refute
the ability of the mammalian organelle to import RNA from the cytoplasm. Moreover, the
mitochondrial import of small amounts of RNA may indicate on a regulatory function of these
molecules, for instance, 5S rRNA might participate in the assembly of mitochondrial ribosome
(I. Tarassov, in preparation).
Even being rather inefficient compared to protein mitochondrial import, RNA targeting
can be used to address into human mitochondria tRNA molecules replacing those affected by
mtDNA mutation [18, 35] or the anti-replicative oligonucleotides with a therapeutic potential
[12, 19, 36].
We previously demonstrated that 5S rRNA can function as a vector to deliver oligoribonu-
cleotides into human mitochondria, and this principle has been successfully applied by three
MtDNA heteroplasmy modulation
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independent laboratories [30, 37, 38]. In the present study, we analyzed mitochondrial import
of four 5S rRNA molecules bearing the 14–15 bases substitutions in the distal portion of the β-
domain. We detected the presence of all the rec.5S rRNA versions in purified mitoplasts, and
their import efficiencies were close to that of endogenous wild type 5S rRNA.
In contrast to small artificial anti-replicative RNAs used previously for the transient trans-
fection of human cells [19], recombinant molecules based on 5S rRNA structure can be
expressed in cells in a stable manner due to the internal promoter region recognized by RNA
Polymerase III, then be processed, exported from the nucleus and imported into mitochondria.
Nevertheless, the discrepancy between 100–200 copies of wild-type 5S rRNA gene and a
unique gene of rec.5S rRNA per genome creates a competition between 5S rRNA molecules
for the transcription, maturation and export protein factors. Thus, the high expression of
rec.5S rRNA molecules in human cells should be a prerequisite of their anti-replicative activity.
Expression of anti-replicative rec.5S rRNA molecules
In the present study, we used the Flp recombinase-mediated integration of a gene of interest
into transcriptionally active genomic location. This approach allowed an improvement of
rec.5S rRNAs expression compared to the random insertion of plasmid DNA bearing rec.5S
rRNA genes [12]. Nevertheless, a significant heteroplasmy shift has been detected in cells bear-
ing only one version of rec.5S rRNA genes, namely 5S-KSS-13H, expressed at the high level
(Table 2). Lower expression of the same molecule did not affect mutant mtDNA load, indicat-
ing on an anti-replicative RNA concentration threshold. Surprisingly, 5S-KSS-15H version,
which differs by 2 bp longer duplex predicted with mutant mtDNA, provided only a small het-
eroplasmy decrease. This can be explained by a slightly lower expression and lower mitochon-
drial import of this RNA. Another difference between these constructs consists in direct
orientation of 5S-KSS-15H gene in respect to CMV promoter in the pcDNA™5/FRT/TO clon-
ing vector, in contrast with the inverse orientation of 5S-KSS-13H gene. Thus, we cannot
exclude possible synthesis of a longer 5S-KSS-15H transcript from external CMV promoter,
which could be detected by RT-PCR therefore compromising the full-size 5S-KSS-15H RNA
quantification. These considerations should be taken into account in the further studies aim-
ing to increase the expression of anti-replicative RNA molecules in a more reproducible way
by using constructs bearing only promoters for RNA polymerase III.
The mechanism of human mtDNA replication is still a subject of intense debate (rev. in
[39]). The idea of anti-replicative heteroplasmy shift as a therapeutic strategy [11] was initially
based on the strand-displacement mtDNA replication model [40] that suggested the existence
of long single-stranded replication intermediates (S4 Fig). Discovery of RNA-DNA hybrid
intermediates gave rise to RITOLS model (Ribonucleotide Incorporation Throughout the Lag-
ging Strand) [41]. A third model proposed conventional strand-coupled DNA synthesis, initi-
ating from sites dispersed across the broad zone named ori Z [42]. Apparently, all the three
mtDNA replication mechanisms can take place in mitochondria, depending on the growth
conditions and the energetic state of the cells. For instance, recent analysis of mtDNA replica-
tion in mice tissues had shown that liver and kidney cells use the asynchronous mechanism,
while heart, brain and skeletal muscle employ a strand-coupled replication mode [43].
Previously, we have directly demonstrated mtDNA replication stalling induced by small
anti-replicative RNA, detected as a new replication intermediate on 2D agarose gel [12]. This
stalling, occurred at the site of the RNA annealing due to impairing of the replication fork pro-
gression, which can be suggested for all the three current models of mtDNA replication (S4
Fig), since the replisome helicase is unable to displace RNA from the short RNA-DNA hybrids
[42]. Our present data indicate that anti-replicative RNAs 5S-KSS-13H and 5S-KSS-15H,
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bearing insertions complementary to mtDNA L-strand, are able to induce a downshift of the
KSS mutation load. Expression of two other rec.5S rRNA versions, 5S-KSS-14L and 5S-KSS-
15L, designed to target the H-strand of mtDNA, had no significant impact on the KSS hetero-
plasmy level. This can be related to asymmetric strand-displacement mechanism of human
mtDNA replication, supposing that at the first step, only L-strand is used as a template for
DNA synthesis [40], therefore, its targeting by anti-replicative RNAs 5S-KSS-13H and 5S-KSS-
15H, as shown schematically on S4 Fig, should be more efficient compared to the H-strand tar-
geting RNAs. This is relevant to recently published data providing a strong support of the
strand-displacement model of mtDNA replication in cultured cells [44].
One should also take into account that melting temperatures predicted for rec.5S rRNA-
mtDNA duplexes are lower for 5S-KSS-14L and 5S-KSS-15L versions (45.2˚C and 48.9˚C)
compared to 5S-KSS-13H and 5S-KSS-15H ones (52.1˚C and 56.6˚C, Fig 2). This can provide
another reason for the poor anti-replicative abilities of 5S-KSS-L versions. Noteworthy, a very
recent paper from the lab of Pierre Rustin [45] provided a set of evidences that human mito-
chondria are maintained at close to 50˚C if the respiratory chain is functional. We can hypoth-
esize that in fully active mitochondria, 5S-KSS-14L and 5S-KSS-15L RNAs cannot anneal to
mtDNA due to increased temperature in mitochondrial matrix.
All these considerations will help to optimize the anti-replicative RNA structure and to
design rec.5S rRNA molecules targeting not only mtDNA deletions, but also pathogenic point
mutations, as it was done for small artificial RNAs [12].
Selective cell growth conditions improved the anti-replicative RNA effect
Warburg and Crabtree effects describe the ability of rapidly proliferating cells to favor glycoly-
sis. Recent studies suggest that cells can adapt to mitochondrial dysfunction by switching to
glycolysis, despite aerobic conditions [46]. Development of transmitochondrial cybrids by
fusion of enucleated somatic cells harboring pathological mtDNA mutations with a cell line
depleted of their mtDNA has enabled the study of consequences of mtDNA mutations [47].
However, cybrid cells cultured in media with high concentrations of glucose tend to acquire
highly glycolytic phenotypes, which make them less suitable as models for studying mitochon-
drial dysfunction.
Attempts have been made to overcome this phenomenon, by substituting glucose with galac-
tose, which does not support anaerobic glycolysis [48]. This is usually explained by the fact that
galactose cannot be oxidized to pyruvate without prior conversion to glucose, which consumes
two molecules of ATP, thus making anaerobic glycolysis useless as a source of energy [49]. Nev-
ertheless, some cell lines cannot utilize galactose, but can grow in a carbohydrate-free media,
apparently relying on the metabolism of pyruvate and amino acids, thus galactose-containing
media can be replaced by carbohydrate-free ones. It was demonstrated that the activity of all
respiratory chain complexes tended to be higher in the glucose-starved cells [50], since they are
forced to rely on mitochondrial oxidative phosphorylation to meet their energy requirements.
Previously, few studies addressed the question of metabolically induced mtDNA hetero-
plasmy shifting. The ketogenic medium has been shown to shift the heteroplasmy level of
cybrid cells towards the wild type [51]. Another report demonstrated that the apparently
homoplasmic 100% MELAS cybrid cells kept in low-glucose medium have shifted their hetero-
plasmy level to 90% [52]. However, a more recent publication from the same research team
demonstrated that the improvement of mitochondrial function in MELAS cybrid cells exposed
to a diet combining low glucose and ketone bodies was not connected to a heteroplasmy shift,
but to increase of the mtDNA copy number [53], therefore, the selective pressure alone was
not capable to induce the heteroplasmy shift.
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Noteworthy, in our experiments, shifts in mutant mtDNA proportion have been detected
only for cells cultivated in a medium poor in glucose. These data are in accordance with the
hypothesis that culturing mutant cells in a low-glucose medium and thus forcing them to use
oxidative phosphorylation would create a selective advantage for cells with improved respira-
tion capacities.
Conclusions
In the present study, we attempted to induce the heteroplasmy shifting by stable expression of
anti-replicative 5S rRNA molecules capable to slow the mutant mtDNA replication in human
transmitochondrial cybrid cells and thus decreasing proportion between mutant and wild type
mtDNA molecules. We provide the strategy of anti-replicative rec.5S rRNA selection based on
the melting temperature prediction and analysis of mitochondrial import. The heteroplasmy
shift, dependent on the level of the recombinant 5S rRNA expression and import, can be mod-
ulated by cell growth conditions. Applying selective conditions favorable for the cells where
the mutant mtDNA proportion has been successfully decreased, allowed detection of the
change in heteroplasmy load for cybrid cells bearing a large deletion in mtDNA. In contrast to
recently developed engineered nuclease technology, which induced a substantial off-target
effects and a significant depletion of mtDNA [10], we detected only a small decrease of
mtDNA copy number, which can be caused by the stalling of the mutant KSS genomes replica-
tion. This indicates that the decreased proportion between mutant and wild type mtDNA mol-
ecules is not a consequence of a random repopulation of depleted pool of mtDNA genomes,
but can be induced by the anti-replicative 5S rRNA expression.
Considering the possible therapeutic applications, the advantage of the stable rec.5S rRNA
expression consists in non-reversible heteroplasmy shift, in contrast with a transient KSS
mutation load decrease obtained previously by use of small anti-replicative RNAs [12]. Never-
theless, we detected the obvious limitations of the approach used: need of high level of rec.5S
rRNA expression and an important variability of this level in transfected cells, influencing the
impact on the heteroplasmy. Further development of the strategy can be achieved by integra-
tion of multiple copies of anti-replicative rec.5S rRNA molecules expressed from external
PolIII promoter by use of plasmid or viral vectors.
In conclusion, our data demonstrate that expression of anti-replicative molecules based on
5S rRNA structure in human cybrid cells can induce a stable shift in a heteroplasmy level of
pathogenic mutations in mtDNA. This shift, dependent on the rec.5S rRNA sequence and the
level of its expression, can be modulated by cell growth conditions, thus opening possibility to
improve models of gene therapy exploiting the anti-replicative strategy.
Materials and methods
Human cell lines and culture conditions
Human transmitochondrial cybrid cells containing 65±2% of mtDNA molecules affected by
KSS deletion (nucleotides 8363–15438) obtained by the team of Dr A. Lombes, Inst. Cochin,
Paris [12] were cultivated in DMEM medium (Sigma) containing 4.5 g/L glucose, 0.584 g/L L-
glutamine and supplemented with 50 mg/L uridine and 3.7 g/L sodium bicarbonate (for glu-
cose-rich conditions). For glucose-free conditions, DMEM base (Sigma) was supplemented
with 50 mg/L uridine, 3.7 g/L sodium bicarbonate, 0.584 g/L L-glutamine and 108 mg/L
sodium pyruvate. Cybrid cells transfected with pFRT/lacZeo were cultivated in media contain-
ing 100 μg/mL Zeocin (Invitrogen). Cells transfected with pcDNA™5/FRT/TO were cultivated
in media supplemented with 150μg/mL Hygromycin B-Gold (InvivoGen).
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Design and synthesis of recombinant 5S rRNA molecules
Secondary structures of rec.5S rRNA were predicted using the Mfold software [54] and cor-
rected in accordance with data on human 5S rRNA structure [55]. Analysis of the annealing
between rec.5S rRNAs and the mtDNA was performed by RNAcofold web server, University of
Vienna. To estimate melting temperatures for RNA-DNA duplexes, we used IDT Sci-Tools
OligoAnalyzer 3.1 software [56].
Rec.5S rRNAs were obtained by T7 transcription using the T7 RiboMAX Express Large-
Scale RNA Production System (Promega) and gel-purified. To create PCR templates, we used a
two-step protocol: PCR1 was performed on a plasmid bearing the human 5S rRNA sequence
under the control of the T7 promoter [26] using forward primer n˚1 and reverse primers n˚2 to
5 (S1 Table). Resulting PCR1 product was used as forward primer for PCR2 performed on the
same plasmid template with reverse primer n˚6 creating a DNA fragment containing rec.5S
RNA sequence under the control of the T7 promoter. Plasmid or PCR fragment were cleaved
by BglII (Fast Digest, ThermoScientific) to assure formation of the exact 5S rRNA 3’ end.
Rec.5S rRNA in vitro hybridization and in vivo import test
To test specific rec.5S rRNA annealing with target mtDNA, wild-type or mutant mtDNA frag-
ments (nucleotides 15,251–15,680 of wild-type mtDNA or 8,099–8,365/15,438–15,680 of
mutant mtDNA) were amplified as described previously [12] using primers n˚7 and 8 or n˚8
and 9 respectively, separated on 1% agarose gel, blotted to Amersham Hybond-N membrane
(GE Healthcare) and hybridized with 32P-labeled recombinant RNA in 1X PBS at 37 ˚C.
Hybridization signals were revealed by Typhoon Trio (GE Healthcare).
The in vivo import assay on the cells transfected with rec.5S rRNA molecules was performed
as described previously [17, 26, 27]. Briefly, 40h post transfection, cells were disrupted, mito-
chondria were isolated by differential centrifugation, treated with RNase A (Sigma) 10 μg/ml for
10 min at 25˚C, washed three times, then treated with of 0.1% digitonin (Sigma) solution for 10
min at 25˚C to disrupt the mitochondrial outer membrane. The mitoplast pellet was washed
and resuspended in TRIZol reagent (Invitrogen). RNA isolated from the mitoplasts and from an
aliquot of the transfected cells were separated by 8% urea-PAGE and analysed by Northern blot
hybridization with 32P-labeled oligonucleotide probes (S1 Table, n˚25–29). To avoid the discrep-
ancies caused by the loading of different amounts of material, we used the hybridization signals
corresponding to the mitochondrial tRNAVal as a loading control. Thus, we take into account
not the absolute intensity of hybridization signals but the ratio between the signals correspond-
ing to rec.5S rRNAs and the host mitochondrial valine tRNA either in mitoplast RNA prepara-
tions (Ratio I) or in the total cellular RNA (Ratio II). Import efficiency of each rec.5S rRNA was
calculated as a quadruple ratio between Ratios I and II and expressed in the form of percentage
of the efficiency thus obtained for the endogenous wild type 5S rRNA in non-transfected cells.
Import eff iciency ¼
RI
RII
RI mitoplast RNAð Þ ¼
rec:5S rRNA
mt tRNA Val
RII total RNAð Þ ¼
rec:5S rRNA
mt tRNA Val
Cytosolic contamination was checked by hybridization with a probe to 5.8S rRNA, a compo-
nent of cytosolic ribosomes. The levels of cytosolic contamination were subtracted from the
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import efficiency values for each rec.5S rRNA version (S2 Table). In control experiments, mito-
chondria were lysed before RNase treatments to demonstrate that all the RNAs were completely
degraded (not shown).
Production of a human transmitochondrial cybrid cell line bearing FRT
site
To generate a KSS cybrid cell line bearing an FRT site, we used the Flp-In™ T-Rex™ Core sys-
tem (Invitrogen). Cybrid cells were transfected with the pFRT/lacZeo plasmid according to the
manufacturer’s protocol, and Zeocin-resistant clones were isolated.
To determine the number of FRT sites in each zeocin-resistant clone, genomic DNA was
extracted, digested with HindIII (ThermoScientific), separated on a 1% agarose gel and blotted
to Amersham Hybond-N membrane (GE Healthcare). To detect FRT sites, a fragment of the
lacZ gene was amplified according to the manufacturer’s protocol (Invitrogen) and 32P-
labelled using Prime-a-gene Labelling System (Promega). After hybridization at 65˚C and
washing, signals were revealed by phosphorimaging in Typhon Trio (GE Healthcare).
Specific β-galactosidase activity in cellular lysate were determined for each clone by use of
the β-gal assay kit (Invitrogen) following manufacturer’s instructions and quantified as nmol
of hydrolyzed substrate ONPG/30 min/mg of cellular protein.
Generation of transmitochondrial cybrid cell lines expressing rec.5S rRNA
Rec.5S rRNA genes were obtained by a two-step protocol: 1) PCR1 with partially overlapping
primers: forward primers n˚10 (for 5S-KSS-15H and 5S-KSS-15L) or n˚12 (for 5S-KSS-13H
and 5S-KSS-14L) and reverse primers n˚2 to 5. 2) Resulting DNA fragments were used as for-
ward primers for PCR2 with reverse primer n˚11 (for 5S-KSS-15H and 5S-KSS-15L) or n˚13
(for 5S-KSS-13H and 5S-KSS-14L) and a plasmid containing human 5S rRNA gene with flank-
ing regions [26] as a template.
Then, rec.5S rRNA genes were cloned into the pcDNA™5/FRT/TO plasmid vector (Invitro-
gen) and verified by sequence analysis. Cybrid FRT-KSS cells were co-transfected with
pcDNA™5/FRT/TO-rec.5S rRNA constructs and pOG44 plasmid encoding Flp recombinase
(Invitrogen) at a molar ratio 1:10 using Lipofectamine 2000 (Invitrogen). Forty-eight hours
after transfection, Hygromycin B-gold (150μg/mL) (Invitrogen) was added to the medium for
selection.
Rec.5S rRNA quantification
Total cellular RNA was isolated with TRIZol reagent (Invitrogen). Levels of rec.5S rRNA
expression were assayed by semi-quantitative RT-PCR with forward primers specific to the
anti-replicative insert (primers n˚18 to 21) (S1 Table) and reverse primer corresponding to the
3’-end of 5S rRNA (primer n˚22) using One-step RT-PCR kit (QIAGEN). For each recombi-
nant RNA, serial dilutions of the corresponding T7-transcript were used to create a calibration
curve and thus estimate the amount of rec.5S rRNA molecules per cell. Control no-RT reac-
tions were performed for each RNA sample. RT-PCR products were PAGE separated, visual-
ized by ethidium bromide staining and quantified using G-box Software. This approach
provided reproducible data, SD = 15–20%.
RT-qPCR was performed in two steps, first by reverse transcriptase Revertaid H minus
(Thermofisher) with primer n˚22, second by real-time qPCR kit Sso Advanced Universal
SYBR Green Supermix (Biorad), primers n˚18 to 21 (S1 Table), in triplicates, with no-RT con-
trol reactions. Amplification cycles were performed with C1000 Touch, CFX96™ Real-Time
Detection System thermocycler (BioRad). PCR was performed by initial denaturation at 95˚C
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for 10 min, followed by 40 cycles of 10s at 95˚C and 45s at 55˚C. The threshold cycle (Ct) val-
ues of each sample were used in the post-PCR data analysis by BioRad CFX Manager™ software
3.0. Absolute amounts of cDNA in each reaction were estimated by use of calibration curves
made with corresponding plasmid DNA.
Analysis of the heteroplasmy level and mtDNA copy number
Cells issued from independent transfections were cultivated separately, in 4 parallel cultures
each one, total DNA was isolated from a portion of cells every 2 weeks and analyzed by 2–3
independent qPCR measurements in triplicates.
To isolate total DNA, cells were solubilized in 0.5 ml of buffer containing 10mM Tris–HCl
pH 7.5, 10mM NaCl, 25mM Na-EDTA and 1% SDS. Then, 10 μl of proteinase K solution (20
mg/ml) was added and the mixture was incubated for 2 h at 50˚. Finally, 50 μl of 5M NaCl was
added and DNA was precipitated by isopropanol.
Heteroplasmy level for KSS deletion was analyzed by real-time qPCR using SYBR Green
(C1000 Touch, CFX96™ Real-Time Detection System, BioRad) as described previously [12].
This approach allows quantification of the level of KSS deletion within a sample by comparing
specific amplification of two different mtDNA regions, located within and outside of the dele-
tion, in separate reactions. To improve the accuracy of the test, we estimated absolute amounts
of DNA in each reaction by use of calibration curves and thus we calculated the ratio between
all mtDNA molecules (mutant and wild-type) and the wild-type ones. Differences in KSS dele-
tion level less than 5% were not considered as significant.
Primers are listed in the S1 Table. Two pairs of primers were used: 1) n˚14 and 15 amplify-
ing a 210bp fragment of 12S rRNA gene (nucleotides 1095–1305 in mtDNA) not affected by
the KSS deletion as a value showing all mtDNA molecules, and 2) n˚16 and 17 amplifying a
164 bp fragment in the deleted region (nucleotides 11 614–11 778) as a value showing only
wild-type mtDNA molecules. Nuclear DNA quantification was performed using primers to
rhodanese gene TST1 (S1 Table). All reactions were performed in a 20 μl volume in triplicates.
PCR was performed by initial denaturation at 95˚C for 10 min, followed by 40 cycles of 30s at
95˚C and 30s at 60˚C. The threshold cycle (Ct) values of each sample were used in the post-
PCR data analysis by BioRad CFX Manager™ software 3.0. In each experiment, absolute
amount of DNA templates were determined using serial dilutions of linearized plasmid DNA
bearing a corresponding sequence. The KSS heteroplasmy level was calculated using the for-
mula: mutant mtDNA/total mtDNA = 1 − (WT mtDNA/total mtDNA). Data obtained on
independently cultivated cells (n = 4) by 3–4 independent qPCR measurements were statisti-
cally processed using the two-tailed Student’s t-test; values of p 0.05 (), p 0.001 () were
considered to be statistically significant.
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S1 Fig. Specific annealing of rec.5S rRNAs to mutant KSS mtDNA. Southern hybridization
of wild-type (WT) or KSS mtDNA fragments (Mut) with 32P-labelled rec.5S rRNAs “5S-KSS-
15H” and “5S-KSS-15L” (as indicated at the right) at 37˚C in 1xPBS.
(TIF)
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of rec.5S rRNA variants in total and mitoplast RNA preparations from cells transfected with
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(EthBr) and hybridized with probes indicated at the left, as on Fig 3.
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S3 Fig. Analysis of the FRT site copy number in isolated transmitochondrial cybrid
KSS-FRT cell lines. Southern blot hybridization of genomic DNA from three KSS-FRT clones
(2, 5 and 8) compared to commercial HEK 293 T-Rex™ Flp-In™ cells.
(TIF)
S4 Fig. Schematic representation of three mtDNA replication models and possible effect of
anti-replicative rec.5S rRNA (modified from [12]).
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